Submissions from 2023


Harnessing Transcriptionally driven chromosomal instability adaptation to target therapy-refractory lethal prostate cancer., Brittiny Dhital, Sandra Santasusagna, Perumalraja Kirthika, Michael Xu, Peiyao Li, Marc Carceles-Cordon, Rajesh K. Soni, Zhuoning Li, Ronald C. Hendrickson, Matthew J. Schiewer, William K. Kelly, Cora N. Sternberg, Jun Luo, Amaia Lujambio, Carlos Cordon-Cardo, Monica Alvarez-Fernandez, Marcos Malumbres, Haojie Huang, Adam Ertel, Josep Domingo-Domenech, and Veronica Rodriguez-Bravo


On a Sugar High: Role of O-GlcNAcylation in Cancer, Giang Le Minh, Emily M. Esquea, Riley G. Young, Jessie Huang, and Mauricio J. Reginato


A Global Federated Real-World Data and Analytics Platform for Research, Matvey B. Palchuk, Jack W. London, David Perez-Rey, Zuzanna J. Drebert, Jessamine P. Winer-Jones, Courtney N. Thompson, John Esposito, and Brecht Claerhout


Tumor Matrix Stiffness Provides Fertile Soil for Cancer Stem Cells, Sadegh Safaei, Roya Sajed, Ahmad Shariftabrizi, Shima Dorafshan, Leili Saeednejad Zanjani, Masoumeh Dehghan Manshadi, Zahra Madjd, and Roya Ghods

Submissions from 2022


Is There a Role for Allogeneic Hematopoietic Stem Cell Transplantation for Refractory Follicular Lymphoma?, Yang Yang, Xia Bi, Mia Gergis, and Usama Gergis

Submissions from 2019


Mutation signature analysis identifies increased mutation caused by tobacco smoke associated DNA adducts in larynx squamous cell carcinoma compared with oral cavity and oropharynx., Andrew P. South, Nicoline Y den Breems, Tony Richa, Uche Nwagu, Tingting Zhan, Shiv Poojan, Ubaldo E. Martinez-Outshoorn, Jennifer M. Johnson, Adam J. Luginbuhl, and Joseph Curry

Submissions from 2018


Role of HOX Genes in Stem Cell Differentiation and Cancer., Seema Bhatlekar, Jeremy Z Fields, and Bruce M. Boman


Multiple tumor suppressors regulate a HIF-dependent negative feedback loop via ISGF3 in human clear cell renal cancer., Lili Liao, Zongzhi Z. Liu, Lauren Langbein, Weijia Cai, Eun-Ah Cho, Jie Na, Xiaohua Niu, Wei Jiang, Zhijiu Zhong, Wesley L. Cai, Geetha Jagannathan, Essel Dulaimi, Joseph R. Testa, Robert G. Uzzo, Yuxin Wang, George R. Stark, Jianxin Sun, Stephen C. Peiper, Yaomin Xu, Qin Yan, and Haifeng Yang


Intestinal barrier tightening by a cell-penetrating antibody to Bin1, a candidate target for immunotherapy of ulcerative colitis., Sunil Thomas, Kevther Hoxha, Walker Alexander, John Gilligan, Rima Dilbarova, Kelly Whittaker, Andrew Kossenkov, George C. Prendergast, and James M. Mullin


The Hungry Cancer Patient: A Case of Money Ill Spent., Allison Zibelli

Submissions from 2017


cAMP Signaling Enhances HIV-1 Long Terminal Repeat (LTR)-directed Transcription and Viral Replication in Bone Marrow Progenitor Cells., Anupam Banerjee, Luna Li, Vanessa Pirrone, Fred C. Krebs, Brian Wigdahl, and Michael R. Nonnemacher

Dare More, Do More, Live More: Living Fearlessly Beyond Cancer, Lu Ann Cahn

How to run away from Doctors and Hospitals, Manuel J. Castillo, MD, PhD

Playing signaling chess with the KRAS oncogene, Jonathan Chernoff, MD, PhD

Dysregulation of microRNAs leads to target therapy, Carlo M. Croce, MD

Update on Novel Agents in Prostate Cancer, Elisabeth I. Heath, MD, FACP

Increasing melanoma prevention through feedback of MC1R genotype, Peter A. Kanetsky, PhD, MPH


A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of Melanoma., Clemens Krepler, Katrin Sproesser, Patricia Brafford, Marilda Beqiri, Bradley Garman, Min Xiao, Batool Shannan, Andrea Watters, Michela Perego, Gao Zhang, Adina Vultur, Xiangfan Yin, Qin Liu, Ioannis N Anastopoulos, Bradley Wubbenhorst, Melissa A. Wilson, Wei Xu, Giorgos Karakousis, Michael Feldman, Xiaowei Xu, Ravi Amaravadi, Tara C. Gangadhar, David E. Elder, Lauren E. Haydu, Jennifer A. Wargo, Michael A. Davies, Yiling Lu, Gordon B. Mills, Dennie T. Frederick, Michal Barzily-Rokni, Keith T. Flaherty, Dave S. Hoon, Michael Guarino, Joseph J. Bennett, Randall W. Ryan, Nicholas J. Petrelli, Carol L. Shields, Mizue Terai, Takami Sato, Andrew E. Aplin, Alexander Roesch, David Darr, Steve Angus, Rakesh Kumar, Ensar Halilovic, Giordano Caponigro, Sebastien Jeay, Jens Wuerthner, Annette Walter, Matthias Ocker, Matthew B. Boxer, Lynn Schuchter, Katherine L Nathanson, and Meenhard Herlyn


Cancer-Associated Fibroblasts Neutralize the Anti-tumor Effect of CSF1 Receptor Blockade by Inducing PMN-MDSC Infiltration of Tumors., Vinit Kumar, Laxminarasimha Donthireddy, Douglas Marvel, Thomas Condamine, Fang Wang, Sergio Lavilla-Alonso, Ayumi Hashimoto, Prashanthi Vonteddu, Reeti Behera, Marlee A. Goins, Charles Mulligan, Brian Nam, Neil Hockstein, Fred Denstman, Shanti Shakamuri, David W. Speicher, Ashani T. Weeraratna, Timothy Chao, Robert H. Vonderheide, Lucia R. Languino, Peter Ordentlich, Qin Liu, Xiaowei Xu, Albert Lo, Ellen Puré, Chunsheng Zhang, Andrey Loboda, Manuel A. Sepulveda, Linda A. Snyder, and Dmitry I. Gabrilovich


Functional Studies of CCAAT/Enhancer Binding Protein Site Located Downstream of the Transcriptional Start Site., Yujie Liu, Michael R. Nonnemacher, Aikaterini Alexaki, Vanessa Pirrone, Anupam Banerjee, Luna Li, Evelyn Kilareski, and Brian Wigdahl


Opinion: Inhibition of Blood-Brain Barrier Repair as a Mechanism in HIV-1 Disease., Monique E. Maubert, Brian Wigdahl, and Michael R. Nonnemacher

Population Science: Collaborating to uncover cancer etiology while reflecting on translation to reduce cancer burden, Elizabeth A. Platz, ScD, MPH

3rd Annual Elena Gitelson Memorial Lecture: Hodgkin Lymphoma: Progress Made and Challenges Ahead, Barbara Pro, MD

Genetics Ancestry and Cancer Health Disparities, Camille Ragin, MPH, PHD

Bridging the Gap between Patient-Centered Care and Evidence-Based Medicine: How and Why Communication Matters, Debra Roter, DrPH


Firing Up Instead of Burning Out: Tales from the front line of the Cake Committee, Britainy Stephens, MSW, LSW; Lora Rhodes, MSW, LSW; Alison Petok, MSW, LCSW; and Gregory Garber, MSW, LCSW

The Long Journey to Health Equity in America, Louis W. Sullivan, MD


Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer., Alfonso Urbanucci, Stefan J. Barfeld, Ville Kytölä, Harri M. Itkonen, Ilsa M. Coleman, Daniel Vodák, Liisa Sjöblom, Xia Sheng, Teemu Tolonen, Sarah Minner, Christoph Burdelski, Kati K. Kivinummi, Annika Kohvakka, Steven Kregel, Mandeep Takhar, Mohammed Alshalalfa, Elai Davicioni, Nicholas Erho, Paul Lloyd, R. Jeffrey Karnes, Ashley E. Ross, Edward M. Schaeffer, Donald J. Vander Griend, Stefan Knapp, Eva Corey, Felix Y. Feng, Peter S. Nelson, Fahri Saatcioglu, Karen E. Knudsen, Teuvo L.J. Tammela, Guido Sauter, Thorsten Schlomm, Matti Nykter, Tapio Visakorpi, and Ian G. Mills

Clinical Research Networks: Strategies in Community-Academic Partnerships, Jake Vinson

Epigenetic Approaches to Epithelial Ovarian Cancer, Rugang Zhang

Submissions from 2016


Repurposing atovaquone: Targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells., Marco Fiorillo, Rebecca Lamb, Herbert B Tanowitz, Luciano Mutti, Marija Krstic-Demonacos, Anna Rita Cappello, Ubaldo E. Martinez-Outshoorn, Federica Sotgia, and Michael P Lisanti

Clinical Cancer Genetics: New Opportunities and Challenges, Judy E. Garber, MD, MPH


IDO1 is an Integral Mediator of Inflammatory Neovascularization., Arpita Mondal, Courtney Smith, James B. DuHadaway, Erika Sutanto-Ward, George C. Prendergast, Arturo Bravo-Nuevo, and Alexander J. Muller

Recent 'advances' in breast and ovarian cancer genetics, Katherine L. Nathanson, MD


Cancer stem cell metabolism., Maria Peiris-Pagès, Ubaldo E. Martinez-Outshoorn, Richard G. Pestell, Federica Sotgia, and Michael P Lisanti


Celecoxib inhibits proliferation and survival of chronic myelogeous leukemia (CML) cells via AMPK-dependent regulation of β-catenin and mTORC1/2., Beatrice Riva, Marco De Dominici, Ilaria Gnemmi, Samanta A. Mariani, Alberto Minassi, Valentina Minieri, Paolo Salomoni, Pier Luigi Canonico, Armando A Genazzani, Bruno Calabretta, and Fabrizio Condorelli

Genetic Susceptibility to Epithelial Ovarian Cancer: Progress and Translational Potential, Thomas A. Sellers, PhD, MPH


Prolonged Morphine Exposure Induces Increased Firm Adhesion in an in Vitro Model of the Blood-Brain Barrier., Marianne Strazza, Vanessa Pirrone, Brian Wigdahl, Will Dampier, Wei Lin, Rui Feng, Monique E Maubert, Babette Weksler, Ignacio A Romero, Pierre-Olivier Couraud, and Michael R Nonnemacher

Rethinking Our Roles in Good Dying, Carol Taylor, PhD, MSN, RN

Submissions from 2015

Soft Tissue Sarcoma: Overview of Management, John A. Abraham, MD

Personalized Medicine for Patients with Lymphoma, James Armitage, MD


Comparison of survival in patients with T cell lymphoma after autologous and allogeneic stem cell transplantation as a frontline strategy or in relapsed disease., Amer Beitinjaneh, Rima M. Saliba, L. Jeffrey Medeiros, Francesco Turturro, Gabriela Rondon, Martin Korbling, Luis Fayad, Michelle A. Fanale, Amin M. Alousi, Paolo Anderlini, Oran Betul, Uday R. Popat, Barbara Pro, and Issa F. Khouri

Challenges and Opportunities at the Cancer/Aging Interface, Harvey Jay Cohen, MD

Multi-level perspectives on optimizing the quality of colorectal cancer screening, Chyke A. Doubeni, MD, MPH, FRCS


PKCε Is an Essential Mediator of Prostate Cancer Bone Metastasis., Alvaro Gutierrez-Uzquiza, Cynthia Lopez-Haber University of Pennsylvania, Danielle L. Jernigan, Alessandro Fatatis, and Marcelo G. Kazanietz

Has Genomic Sequencing of Pancreatic Cancers held the field back?, Benjamin E. Leiby, MD

Precision Medicine in Colorectal Cancer: Molecular Factors to Optimize Systemic Therapeutic Decisions and Patient Care, Edith P. Mitchell, MD, FACP

Achieving Health Equity addressing RACISM and other systems of structured inequity, Camara Phyllis Jones, MD, MPH, PhD

Prostate Cancer Disparities: From Nucleotide to Neighborhood, Timothy R. Rebbeck, PhD

Shifting the Prostate Cancer Drug Development Paradigm from Palliation to Cure, Howard I. Scher, MD

Submissions from 2014


Measuring Patient Satisfaction in Multidisciplinary Cancer Centers: Optimize Use of Results to Effect Change and Improve Processes, Mary-Kate Cellmer, BS

Achieving Health Equity: Where does the Health Care's System's Responsibility End?, Karen M. Emmons, PhD

Immature myeloid cells and skin tumor development, Dmitry Gabrilovich

Transplantation for Myeloma-Still Relevant?, Parameswaran Hari, MD

Isoprenoids and Cancer, Raymond J. Hohl, MD, PhD

Thermal Oncology: The Evolving Role of Heat in Multidisciplinary Cancer Care, Mark Hurwitz, MD

An Epigenetic Clock of Lifespan and Cancer, Jean-Pierre Issa, MD

Management of Locally Advanced NSCLC: 25 Years in the Trenches, Corey J. Langer, MD, FACP

The AML Genome(s), Timothy J. Ley, MD

Molecular Landscaping of AML: Are we relearning the Past or Informing the Future?, Guido Marcucci, MD

Navigating the Complex World of Cancer Diagnosis and Care: Minimizing Disparities, Edith Peterson Mitchell, MD, FACP

Advances in Cutaneous Lymphomas: A Multidisciplinary Approach, Barbara Pro, MD

Discovery of New Therapeutic Targets for Prostate Cancer, Owen N. Witte, MD

Submissions from 2013

Genomic Guided Therapy in Cancer Patients, Robert B. Diasio, MD

A 2-Step Approach to Allogeneic Hematopoietic Stem Cell Transplantation, Neal Flomenberg, MD and Dolores Grosso, DNP

Moving Beyond the PSA Controversy: Prostate Screening Controversy and Newer Tests for Prostate Cancer, Leonard G. Gomella

Advances in Non-Small Cell Lung Cancer 2014, Thomas J. Lynch, Jr., MD

A Translational Investigation of Cancer Metastasis, Zhang Ning

Cell Cycle Control of Genomic Signaling, Richard Pestell

Therapeutic Targeting of EMT in Prostate Cancer, Robert R. Reiter, MD, MBA

A circulating free DNA assay, cMethDNA, in serum for detection of metastatic breast cancer and prediction of response to therapy, Sara Sukumar, PhD